{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:38:00Z","timestamp":1790660280238,"version":"4.1.0"},"reference-count":99,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:p>Donation after circulatory death determination frequently involves antemortem heparin administration to mitigate peri-arrest microvascular thrombosis. We systematically reviewed the literature to: (1) describe heparin administration practices and (2) explore the effects on transplant outcomes. We searched MEDLINE and EMBASE for studies reporting donation after circulatory death determination heparin practices including use, dosage, and timing (objective 1). To explore associations between antemortem heparin and transplant outcomes (objective 2), we (1) summarized within-study comparisons and (2) used meta-regression analyses to examine associations between proportions of donors that received heparin and transplant outcomes. We assessed risk of bias using the Newcastle Ottawa Scale and applied the GRADE methodology to determine certainty in the evidence. For objective 1, among 55 eligible studies, 48 reported heparin administration to at least some donors (range: 15.8%\u2013100%) at variable doses (up to 1000 units\/kg) and times relative to withdrawal of life-sustaining therapy. For objective 2, 7 studies that directly compared liver transplants with and without antemortem heparin reported lower rates of primary nonfunction, hepatic artery thrombosis, graft failure at 5 y, or recipient mortality (low certainty of evidence). In contrast, meta-regression analysis of 32 liver transplant studies detected no associations between the proportion of donors that received heparin and rates of early allograft dysfunction, primary nonfunction, hepatic artery thrombosis, biliary ischemia, graft failure, retransplantation, or patient survival (very low certainty of evidence). In conclusion, antemortem heparin practices vary substantially with an uncertain effect on transplant outcomes. Given the controversies surrounding antemortem heparin, clinical trials may be warranted.<\/jats:p>","DOI":"10.1097\/tp.0000000000003793","type":"journal-article","created":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T03:18:05Z","timestamp":1619493485000},"page":"e337-e346","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":13,"title":["Antemortem Heparin in Organ Donation After Circulatory Death Determination: A Systematic Review of the Literature"],"prefix":"10.1097","volume":"105","author":[{"given":"Kimia","family":"Honarmand","sequence":"first","affiliation":[{"name":"Division of Critical Care, Department of Medicine, Western University, London, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fayez","family":"Alshamsi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farid","family":"Foroutan","sequence":"additional","affiliation":[{"name":"Ted Rogers Centre for Heart Research, Peter Munk Cardiac Center, University Health Network, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bram","family":"Rochwerg","sequence":"additional","affiliation":[{"name":"Division of Critical Care, Department of Medicine, McMaster University, Hamilton, ON, Canada."},{"name":"Department of Health Research Methods, Evidence, and Impact (HEI), McMaster University, Hamilton, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Belley-Cote","sequence":"additional","affiliation":[{"name":"Division of Critical Care, Department of Medicine, McMaster University, Hamilton, ON, Canada."},{"name":"Department of Health Research Methods, Evidence, and Impact (HEI), McMaster University, Hamilton, ON, Canada."},{"name":"Division of Cardiology, Department of Medicine, McMaster University, Hamilton, Canada."},{"name":"Population Health Research Institute, Hamilton, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Mclure","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact (HEI), McMaster University, Hamilton, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick","family":"D\u2019Aragon","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Universit\u00e9 de Sherbrooke, Sherbrooke, QC, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian M.","family":"Ball","sequence":"additional","affiliation":[{"name":"Division of Critical Care, Department of Medicine, Western University, London, ON, Canada."},{"name":"Department of Epidemiology and Biostatistics, Western University, London, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alp","family":"Sener","sequence":"additional","affiliation":[{"name":"Department of Surgery and Microbiology and Immunology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Selzner","sequence":"additional","affiliation":[{"name":"Multi-Organ Transplant Program, Department of Surgery, Toronto General Hospital, University Health Network, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Guyatt","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact (HEI), McMaster University, Hamilton, ON, Canada."},{"name":"Department of Medicine, McMaster University, Hamilton, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen O.","family":"Meade","sequence":"additional","affiliation":[{"name":"Division of Critical Care, Department of Medicine, McMaster University, Hamilton, ON, Canada."},{"name":"Department of Health Research Methods, Evidence, and Impact (HEI), McMaster University, Hamilton, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,11,22]]},"reference":[{"key":"R4-20250607","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/MOT.0000000000000179","article-title":"Donation after circulatory death: the current state and technical approaches to organ procurement.","volume":"20","author":"Algahim","year":"2015","journal-title":"Curr Opin Organ Transplant"},{"key":"R5-20250607","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/SLA.0b013e318273bef1","article-title":"Ex vivo lung evaluation of prearrest heparinization in donation after cardiac death.","volume":"257","author":"Sanchez","year":"2013","journal-title":"Ann Surg"},{"key":"R6-20250607","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0003-4975(01)02959-9","article-title":"Heparin and the nonanticoagulant N-acetyl heparin attenuate capillary no-reflow after normothermic ischemia of the lung.","volume":"72","author":"Nakamura","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"R7-20250607","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.thromres.2006.10.026","article-title":"The anti-inflammatory effects of heparin and related compounds.","volume":"122","author":"Young","year":"2008","journal-title":"Thromb Res"},{"key":"R8-20250607","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.profnurs.2005.01.005","article-title":"The ethics of heparin administration to the potential non-heart-beating organ donor.","volume":"21","author":"Motta","year":"2005","journal-title":"J Prof Nurs"},{"key":"R9-20250607","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/TP.0b013e31824836fa","article-title":"Whose consent matters? Controlled donation after cardiac death and premortem organ-preserving measures.","volume":"93","author":"Bastami","year":"2012","journal-title":"Transplantation"},{"key":"R10-20250607","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1007\/s12630-020-01692-7","article-title":"Variability in deceased donor care in Canada: a report of the Canada-DONATE cohort study.","volume":"67","author":"D\u2019Aragon","year":"2020","journal-title":"Can J Anaesth"},{"key":"R11-20250607","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1164\/rccm.201304-0714ST","article-title":"An official American Thoracic Society\/International Society for Heart and Lung Transplantation\/Society of Critical Care Medicine\/Association of Organ and Procurement Organizations\/United Network of Organ Sharing Statement: ethical and policy considerations in organ donation after circulatory determination of death.","volume":"188","author":"Gries","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"R13-20250607","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1503\/cmaj.060895","article-title":"National recommendations for donation after cardiocirculatory death in Canada: donation after cardiocirculatory death in Canada.","volume":"175","author":"Shemie","year":"2006","journal-title":"CMAJ"},{"key":"R16-20250607","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence.","volume":"64","author":"Balshem","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"R17-20250607","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jclinepi.2012.01.006","article-title":"GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes.","volume":"66","author":"Guyatt","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"R18-20250607","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jclinepi.2013.02.004","article-title":"The GRADE approach is reproducible in assessing the quality of evidence of quantitative evidence syntheses.","volume":"66","author":"Mustafa","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"R19-20250607","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1002\/lt.21212","article-title":"Biliary complications and outcomes of liver transplantation from donors after cardiac death.","volume":"13","author":"Maheshwari","year":"2007","journal-title":"Liver Transpl"},{"key":"R20-20250607","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1600-6143.2009.02560.x","article-title":"Liver transplantation using donation after cardiac death donors: long-term follow-up from a single center.","volume":"9","author":"de Vera","year":"2009","journal-title":"Am J Transplant"},{"key":"R21-20250607","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.surg.2009.06.052","article-title":"The impact of ischemic cholangiopathy in liver transplantation using donors after cardiac death: the untold story.","volume":"146","author":"Skaro","year":"2009","journal-title":"Surgery"},{"key":"R22-20250607","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1600-6143.2009.02965.x","article-title":"Liver transplantation with grafts from controlled donors after cardiac death: a 20-year follow-up at a single center.","volume":"10","author":"Yamamoto","year":"2010","journal-title":"Am J Transplant"},{"key":"R23-20250607","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1001\/archsurg.2011.240","article-title":"Liver transplantation using organ donation after cardiac death: a clinical predictive index for graft failure-free survival.","volume":"146","author":"Hong","year":"2011","journal-title":"Arch Surg"},{"key":"R24-20250607","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1477-2574.2011.00307.x","article-title":"Minimising cold ischaemic time is essential in cardiac death donor-associated liver transplantation.","volume":"13","author":"Karp","year":"2011","journal-title":"HPB (Oxford)"},{"key":"R25-20250607","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.surg.2011.07.057","article-title":"Donation after cardiac death: a 29-year experience.","volume":"150","author":"Bellingham","year":"2011","journal-title":"Surgery"},{"key":"R26-20250607","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1432-2277.2012.01508.x","article-title":"Asystole to cross-clamp period predicts development of biliary complications in liver transplantation using donation after cardiac death donors.","volume":"25","author":"Taner","year":"2012","journal-title":"Transpl Int"},{"key":"R27-20250607","doi-asserted-by":"crossref","first-page":"154","DOI":"10.6002\/ect.2012.0173","article-title":"Liver transplant using donors after cardiac death: a single-center approach providing outcomes comparable to donation after brain death.","volume":"11","author":"Vanatta","year":"2013","journal-title":"Exp Clin Transplant"},{"key":"R28-20250607","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1111\/ajt.12927","article-title":"In situ normothermic regional perfusion for controlled donation after circulatory death\u2013the United Kingdom experience.","volume":"14","author":"Oniscu","year":"2014","journal-title":"Am J Transplant"},{"key":"R29-20250607","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S1499-3872(14)60274-5","article-title":"Liver transplantation using organs from deceased organ donors: a single organ transplant center experience.","volume":"13","author":"Han","year":"2014","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"R30-20250607","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/lt.23777","article-title":"Donor hemodynamic profile presages graft survival in donation after cardiac death liver transplantation.","volume":"20","author":"Abt","year":"2014","journal-title":"Liver Transpl"},{"key":"R31-20250607","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/bjs.9488","article-title":"Donor age as a risk factor in donation after circulatory death liver transplantation in a controlled withdrawal protocol programme.","volume":"101","author":"Detry","year":"2014","journal-title":"Br J Surg"},{"key":"R32-20250607","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/lt.24316","article-title":"Impact of donor age in liver transplantation from donation after circulatory death donors: a decade of experience at Cleveland Clinic.","volume":"21","author":"Firl","year":"2015","journal-title":"Liver Transpl"},{"key":"R33-20250607","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/ajt.12962","article-title":"Differential rates of ischemic cholangiopathy and graft survival associated with induction therapy in DCD liver transplantation.","volume":"15","author":"Halldorson","year":"2015","journal-title":"Am J Transplant"},{"key":"R34-20250607","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/lt.24123","article-title":"Donation after cardiac death liver transplantation: graft quality evaluation based on pretransplant liver biopsy.","volume":"21","author":"Xia","year":"2015","journal-title":"Liver Transpl"},{"key":"R35-20250607","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.3748\/wjg.v22.i12.3392","article-title":"Donor preoperative oxygen delivery and post-extubation hypoxia impact donation after circulatory death hypoxic cholangiopathy.","volume":"22","author":"Chirichella","year":"2016","journal-title":"World J Gastroenterol"},{"key":"R36-20250607","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.resuscitation.2017.05.030","article-title":"Validation of a new proposal to avoid donor resuscitation in controlled donation after circulatory death with normothermic regional perfusion.","volume":"117","author":"Perez-Villares","year":"2017","journal-title":"Resuscitation"},{"key":"R37-20250607","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1111\/ajt.14261","article-title":"Safety and outcomes in 100 consecutive donation after circulatory death liver transplants using a protocol that includes thrombolytic therapy.","volume":"17","author":"Bohorquez","year":"2017","journal-title":"Am J Transplant"},{"issue":"Suppl 2","key":"R38-20250607","first-page":"40","article-title":"108 sequential donation after cardiac death liver transplants without recipient thrombolytic therapy.","volume":"18","author":"LaMattina","year":"2018","journal-title":"Am J Transplant"},{"issue":"Suppl 4","key":"R39-20250607","first-page":"908","article-title":"High dose tissue plasminogen activator flush during donation-after-cardiac-death (DCD) liver procurements offers optimal outcomes.","volume":"18","author":"Torabi","year":"2018","journal-title":"Am J Transplant"},{"key":"R40-20250607","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/lt.25068","article-title":"Expanding the donor pool: donation after circulatory death and living liver donation do not compromise the results of liver transplantation.","volume":"24","author":"Kollmann","year":"2018","journal-title":"Liver Transpl"},{"issue":"Suppl 2","key":"R41-20250607","first-page":"2","article-title":"Controlled donation after circulatory death (cDCD) in Donostia University Hospital, 2015-2018.","volume":"6","author":"de Almeida","year":"2018","journal-title":"Intensive Care Med Exp"},{"key":"R42-20250607","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1097\/TP.0000000000002518","article-title":"Impact of donor hepatectomy time during organ procurement in donation after circulatory death liver transplantation: the United Kingdom experience.","volume":"103","author":"Farid","year":"2019","journal-title":"Transplantation"},{"key":"R43-20250607","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1002\/lt.25462","article-title":"Expanding the donor pool with the use of extended criteria donation after circulatory death livers.","volume":"25","author":"Mihaylov","year":"2019","journal-title":"Liver Transpl"},{"key":"R44-20250607","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1097\/TP.0000000000002391","article-title":"Favorable outcomes after liver transplantation with normothermic regional perfusion from donors after circulatory death: a single-center experience.","volume":"103","author":"Ruiz","year":"2019","journal-title":"Transplantation"},{"key":"R45-20250607","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1503\/cjs.012017","article-title":"Can we reduce ischemic cholangiopathy rates in donation after cardiac death liver transplantation after 10 years of practice? Canadian single-centre experience.","volume":"62","author":"Tun-Abraham","year":"2019","journal-title":"Can J Surg"},{"issue":"Suppl 2","key":"R46-20250607","first-page":"21","article-title":"Controlled donation after cardiac death donors are prothrombotic and have diminished fibrinolysis: implications in liver transplantation.","volume":"20","author":"Crannell","year":"2020","journal-title":"Am J Transplant"},{"key":"R47-20250607","doi-asserted-by":"crossref","first-page":"e13763","DOI":"10.1111\/ctr.13763","article-title":"Results in liver transplantation using grafts from donors after controlled circulatory death: a single-center experience comparing donor grafts harvested after controlled circulatory death to those harvested after brain death.","volume":"34","author":"Otero","year":"2020","journal-title":"Clin Transplant"},{"key":"R48-20250607","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s12630-020-01594-8","article-title":"Donation after circulatory determination of death in western Canada: a multicentre study of donor characteristics and critical care practices.","volume":"67","author":"Kramer","year":"2020","journal-title":"Can J Anaesth"},{"key":"R49-20250607","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.surg.2020.02.005","article-title":"Donor hepatectomy time influences ischemia-reperfusion injury of the biliary tree in donation after circulatory death liver transplantation.","volume":"168","author":"van Leeuwen","year":"2020","journal-title":"Surgery"},{"issue":"1 Pt 2","key":"R50-20250607","first-page":"1215","article-title":"Clinical application of in situ renal cooling: experience with 61 cardiac-arrest donors.","volume":"21","author":"Fujita","year":"1989","journal-title":"Transplant Proc"},{"key":"R51-20250607","first-page":"710","article-title":"Liver and kidney transplantation from non-heart beating donors: the Pittsburgh experience.","volume":"27","author":"Casavilla","year":"1995","journal-title":"Transplant Proc"},{"key":"R52-20250607","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S0041-1345(00)02457-X","article-title":"Multivariate analyses of factors contributing to early graft function in 759 kidney transplants from non-heart-beating donors.","volume":"33","author":"Teraoka","year":"2001","journal-title":"Transplant Proc"},{"key":"R53-20250607","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cccn.2003.07.023","article-title":"Do tissue damage biomarkers used to assess machine-perfused NHBD kidneys predict long-term renal function post-transplant?","volume":"338","author":"Gok","year":"2003","journal-title":"Clin Chim Acta"},{"key":"R54-20250607","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1432-2277.2011.01402.x","article-title":"Results of kidney transplantation from controlled donors after cardio-circulatory death: a single center experience.","volume":"25","author":"Ledinh","year":"2012","journal-title":"Transpl Int"},{"key":"R55-20250607","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jamcollsurg.2010.12.033","article-title":"Lessons learned from a single center\u2019s experience with 134 donation after cardiac death donor kidney transplants.","volume":"212","author":"Farney","year":"2011","journal-title":"J Am Coll Surg"},{"key":"R56-20250607","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s12630-011-9511-9","article-title":"Organ donation after cardiac death: donor and recipient outcomes after the first three years of the Ontario experience.","volume":"58","author":"Hernadez-Alejandro","year":"2011","journal-title":"Can J Anaesth"},{"key":"R57-20250607","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/j.transproceed.2013.02.128","article-title":"Outcome of renal transplantation from deceased donors after cardiac death: a single-center experience from a developing country.","volume":"45","author":"Kute","year":"2013","journal-title":"Transplant Proc"},{"key":"R58-20250607","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1097\/TP.0000000000000899","article-title":"Outcomes of kidney transplant recipients from donation after circulatory death donors without preagonal heparin administration.","volume":"99","author":"Kamal","year":"2015","journal-title":"Transplantation"},{"key":"R59-20250607","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/ctr.12647","article-title":"Enhancing kidney function with thrombolytic therapy following donation after cardiac death: a multicenter quasi-blinded prospective randomized trial.","volume":"29","author":"Woodside","year":"2015","journal-title":"Clin Transplant"},{"key":"R60-20250607","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/ajt.13432","article-title":"Donor hemodynamics as a predictor of outcomes after kidney transplantation from donors after cardiac death.","volume":"16","author":"Allen","year":"2016","journal-title":"Am J Transplant"},{"key":"R61-20250607","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1177\/0310057X1604400402","article-title":"Organ donation after circulatory death in a university teaching hospital.","volume":"44","author":"Sidiropoulos","year":"2016","journal-title":"Anaesth Intensive Care"},{"issue":"11 Suppl 1","key":"R62-20250607","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1097\/01.tp.0000611828.58341.c7","article-title":"Similar 1-year organ function from controlled donation after circulatory death using normo-thermic regional perfusion and donation after brain death.","volume":"103","author":"Foss","year":"2019","journal-title":"Transplantation"},{"issue":"Suppl 2","key":"R63-20250607","first-page":"S103","article-title":"The use of non-heart-beating lung donors category III can increase the donor pool.","volume":"11","author":"Van De Wauwer","year":"2010","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"R64-20250607","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1111\/j.1600-6143.2012.04193.x","article-title":"Excellent clinical outcomes from a national donation-after-determination-of-cardiac-death lung transplant collaborative.","volume":"12","author":"Levvey","year":"2012","journal-title":"Am J Transplant"},{"key":"R65-20250607","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/ajt.13124","article-title":"Lung transplantation with donation after circulatory determination of death donors and the impact of ex vivo lung perfusion.","volume":"15","author":"Machuca","year":"2015","journal-title":"Am J Transplant"},{"key":"R66-20250607","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.athoracsur.2017.07.023","article-title":"Use of lung allografts from donation after cardiac death donors: a single-center experience.","volume":"105","author":"Costa","year":"2018","journal-title":"Ann Thorac Surg"},{"key":"R67-20250607","doi-asserted-by":"crossref","first-page":"296","DOI":"10.5761\/atcs.oa.18-00098","article-title":"Lung transplantation with controlled donation after circulatory death donors.","volume":"24","author":"Inci","year":"2018","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"R68-20250607","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/ajt.15520","article-title":"Combined lung and liver procurement in controlled donation after circulatory death using normothermic abdominal perfusion. Initial experience in two Spanish centers.","volume":"20","author":"Mi\u00f1ambres","year":"2020","journal-title":"Am J Transplant"},{"key":"R69-20250607","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1111\/j.1600-6143.2012.04075.x","article-title":"Pancreas transplantation from donors after circulatory death from the United Kingdom.","volume":"12","author":"Muthusamy","year":"2012","journal-title":"Am J Transplant"},{"key":"R70-20250607","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/01.sla.0000186175.84788.50","article-title":"Simultaneous pancreas-kidney transplantation from donation after cardiac death: successful long-term outcomes.","volume":"242","author":"Fernandez","year":"2005","journal-title":"Ann Surg"},{"key":"R71-20250607","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.transproceed.2019.01.050","article-title":"Simultaneous pancreas-kidney transplant from donors after brain death vs donors after circulatory death: a single-center follow-up study over 3 decades.","volume":"51","author":"Romano","year":"2019","journal-title":"Transplant Proc"},{"key":"R72-20250607","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/TP.0000000000001940","article-title":"Pancreas transplantation with grafts from donors deceased after circulatory death: 5 years single-center experience.","volume":"102","author":"Kopp","year":"2018","journal-title":"Transplantation"},{"key":"R73-20250607","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/lt.23871","article-title":"Inferior long-term outcomes of liver-kidney transplantation using donation after cardiac death donors: single-center and organ procurement and transplantation network analyses.","volume":"20","author":"Wadei","year":"2014","journal-title":"Liver Transpl"},{"key":"R74-20250607","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/lt.25685","article-title":"Transplant outcomes of donation after circulatory death livers recovered with versus without premortem heparin administration.","volume":"26","author":"Narvaez","year":"2020","journal-title":"Liver Transpl"},{"key":"R75-20250607","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/lt.21361","article-title":"Ischemic cholangiopathy following liver transplantation from donation after cardiac death donors.","volume":"14","author":"Chan","year":"2008","journal-title":"Liver Transpl"},{"key":"R76-20250607","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1432-2277.2009.01029.x","article-title":"Liver transplantation from donation after cardiac death donors: initial Belgian experience 2003-2007.","volume":"23","author":"Detry","year":"2010","journal-title":"Transpl Int"},{"key":"R77-20250607","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.transproceed.2004.12.021","article-title":"Livers transplanted from donors after cardiac death occurring in the ICU or the operating room have excellent outcomes.","volume":"37","author":"Olson","year":"2005","journal-title":"Transplant Proc"},{"issue":"Suppl 1","key":"R78-20250607","first-page":"831A","article-title":"Pre-transplant portal vein thrombosis is an independent risk factor for graft loss due to hepatic artery thrombosis in liver transplant recipients.","volume":"62","author":"Stine","year":"2015","journal-title":"Hepatology"},{"issue":"Suppl 2","key":"R79-20250607","first-page":"84","article-title":"Liver transplantation from donation after cardiocirculatory death (DCD) donors: Belgian experience 2003-2009.","volume":"24","author":"De Roover","year":"2011","journal-title":"Transpl Int"},{"issue":"Suppl 10S","key":"R80-20250607","first-page":"S263","article-title":"Predictors of early graft loss in donation after circulatory death liver transplantation.","volume":"96","author":"Riddiough","year":"2013","journal-title":"Transplantation"},{"key":"R81-20250607","doi-asserted-by":"crossref","first-page":"e13624","DOI":"10.1111\/ctr.13624","article-title":"Outcomes of DCD kidneys recovered for transplantation with versus without pre-mortem heparin administration.","volume":"33","author":"Narvaez","year":"2019","journal-title":"Clin Transplant"},{"issue":"Suppl 3","key":"R82-20250607","first-page":"40","article-title":"Variations in DCD procurement procedures across OPOs and their effects on kidney transplant outcomes.","volume":"20","author":"Choubey","year":"2020","journal-title":"Am J Transplant"},{"issue":"Suppl 1","key":"R83-20250607","first-page":"42","article-title":"Transplant outcomes of donation after circulatory death kidneys recovered with versus without pre-recovery heparin administration.","volume":"19","author":"Narvaez","year":"2019","journal-title":"Am J Transplant"},{"key":"R84-20250607","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/lt.25410","article-title":"Retrieval practice or overall donor and recipient risk: what impacts on outcomes after donation after circulatory death liver transplantation in the United Kingdom?","volume":"25","author":"Boteon","year":"2019","journal-title":"Liver Transpl"},{"key":"R85-20250607","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1097\/TP.0000000000001204","article-title":"Optimization of perioperative conditions to prevent ischemic cholangiopathy in donation after circulatory death donor liver transplantation.","volume":"100","author":"Kubal","year":"2016","journal-title":"Transplantation"},{"key":"R86-20250607","doi-asserted-by":"crossref","first-page":"e13068","DOI":"10.1111\/ctr.13068","article-title":"The influence of functional warm ischemia time on DCD liver transplant recipients\u2019 outcomes.","volume":"31","author":"Coffey","year":"2017","journal-title":"Clin Transplant"},{"key":"R87-20250607","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/01.TP.0000062574.18648.7C","article-title":"Liver transplantation from controlled non-heart-beating donors: an increased incidence of biliary complications.","volume":"75","author":"Abt","year":"2003","journal-title":"Transplantation"},{"key":"R88-20250607","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/SLA.0b013e3182104784","article-title":"Biliary complications after liver transplantation from donation after cardiac death donors: an analysis of risk factors and long-term outcomes from a single center.","volume":"253","author":"Foley","year":"2011","journal-title":"Ann Surg"},{"key":"R89-20250607","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1007\/s12072-010-9242-y","article-title":"The clinical consequences of utilizing donation after cardiac death liver grafts into hepatitis C recipients.","volume":"5","author":"Mawardi","year":"2011","journal-title":"Hepatol Int"},{"key":"R90-20250607","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/01.sla.0000186178.07110.92","article-title":"Donation after cardiac death: the University of Wisconsin experience with liver transplantation.","volume":"242","author":"Foley","year":"2005","journal-title":"Ann Surg"},{"key":"R91-20250607","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1111\/j.1600-6143.2010.03337.x","article-title":"Use of tissue plasminogen activator in liver transplantation from donation after cardiac death donors.","volume":"10","author":"Hashimoto","year":"2010","journal-title":"Am J Transplant"},{"issue":"Suppl 2","key":"R92-20250607","first-page":"94","article-title":"No ischemic cholangiopathy following liver transplantation from DCD donors: implementation of selective organ recovery criteria and TPA administration before cold perfusion.","volume":"14","author":"Kishi","year":"2014","journal-title":"Am J Transplant"},{"key":"R93-20250607","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1097\/SLA.0000000000003540","article-title":"Transplantation of high-risk donor livers after ex situ resuscitation and assessment using combined hypo- and normothermic machine perfusion: a prospective clinical trial.","volume":"270","author":"van Leeuwen","year":"2019","journal-title":"Ann Surg"},{"key":"R94-20250607","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jamcollsurg.2015.03.053","article-title":"Outcomes using grafts from donors after cardiac death.","volume":"221","author":"Doyle","year":"2015","journal-title":"J Am Coll Surg"},{"key":"R95-20250607","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jhep.2018.12.033","article-title":"Survival advantage for patients accepting the offer of a circulatory death liver transplant.","volume":"70","author":"Taylor","year":"2019","journal-title":"J Hepatol"},{"key":"R96-20250607","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1097\/TP.0000000000001175","article-title":"Donation after circulatory death for liver transplantation: a meta-analysis on the location of life support withdrawal affecting outcomes.","volume":"100","author":"Cao","year":"2016","journal-title":"Transplantation"},{"key":"R97-20250607","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/TP.0000000000001084","article-title":"Outcomes from pancreatic transplantation in donation after cardiac death: a systematic review and meta-analysis.","volume":"101","author":"Shahrestani","year":"2017","journal-title":"Transplantation"},{"key":"R98-20250607","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1097\/TP.0000000000002888","article-title":"The comparable efficacy of lung donation after circulatory death and brain death: a systematic review and meta-analysis.","volume":"103","author":"Zhou","year":"2019","journal-title":"Transplantation"},{"key":"R99-20250607","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1097\/TP.0000000000001378","article-title":"Premortem heparin administration and location of withdrawal of life-sustaining interventions in DCD: lack of high-quality evidence precludes definitive conclusions.","volume":"100","author":"Kramer","year":"2016","journal-title":"Transplantation"},{"key":"R100-20250607","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/S0022-3468(99)90317-2","article-title":"Pre-arrest heparinization and ventilation during warm ischemia preserves lung function in non-heart-beating donors.","volume":"34","author":"Boglione","year":"1999","journal-title":"J Pediatr Surg"},{"key":"R101-20250607","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.healun.2008.05.019","article-title":"Pre-arrest administration of the cell-permeable free radical scavenger tempol reduces warm ischemic damage of lung function in non-heart-beating donors.","volume":"27","author":"Hodyc","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"R102-20250607","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1432-2277.2000.tb01071.x","article-title":"Heparin and phentolamine combined, rather than heparin alone, improves hepatic microvascular procurement in a non-heart-beating donor rat-model.","volume":"13","author":"Richter","year":"2000","journal-title":"Transpl Int"},{"key":"R103-20250607","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/ejcts\/ezs364","article-title":"Heparin does not improve graft function in uncontrolled non-heart-beating lung donation: an experimental study in pigs.","volume":"43","author":"Wallinder","year":"2013","journal-title":"Eur J Cardiothorac Surg"},{"key":"R104-20250607","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/lt.25013","article-title":"Heparin but not tissue plasminogen activator improves outcomes in donation after circulatory death liver transplantation in a porcine model.","volume":"24","author":"Hessheimer","year":"2018","journal-title":"Liver Transpl"},{"key":"R105-20250607","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.healun.2010.04.007","article-title":"Post-mortem tissue-type plasminogen activator preserves graft function of hearts harvested from non-pre-treated non-heart-beating donors.","volume":"29","author":"Hirota","year":"2010","journal-title":"J Heart Lung Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003793","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T16:13:33Z","timestamp":1749312813000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,22]]},"references-count":99,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000003793","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11,22]]}}}